Using pragmatic rollout strategies to connect Salvation Army clients with evidence-based quitting help
Official title: Using a Pragmatic Randomized Rollout Trial to Evaluate Implementation Strategies to Promote Smoking Treatment and Cancer Prevention for Salvation Army Clients
Funded at University of Wisconsin-Madison · NIH-11457461 · Data updated 2026-11-12
This grant tests new ways to help Salvation Army clients who smoke get free, proven help to quit and lower cancer risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $916,730 |
| NIH project number | 4UH3CA293756-03 |
| Project ID | NIH-11457461 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years and older who are served by Salvation Army agencies and smoke tobacco.
✕Less likely to help
Smokers who do not engage with the quitline or whose circumstances prevent referral may not benefit.
What this research studies
The project partners with Salvation Army agencies to customize and test practical ways to refer clients to the Wisconsin Quit Line for evidence-based tobacco treatment. Researchers will implement two promising strategies in real-world Salvation Army settings and measure how well they work in usual service environments. The study uses pragmatic methods so findings reflect what could happen in everyday practice, not just in ideal conditions. If successful, the approach could be adopted broadly to reduce smoking-related cancer risk in socioeconomically disadvantaged communities.
Why it matters
Potential benefit: If the strategies succeed, more disadvantaged adults who smoke could access effective quitting support, potentially lowering cancer risk.
How similar studies have gone: Preliminary data suggest that staff-assisted quitline referrals can be effective in similar community settings, but this project tests their fit in Salvation Army services.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Mccarthy, Danielle Erin — University of Wisconsin-Madison
- Study coordinator: Mccarthy, Danielle Erin
Related research
Other NIH-funded projects on the same topics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
BSMART: A program to help people with HIV quit smoking
A program in HIV care settings tests a proven plan to help people with HIV quit smoking, using quick counseling and a switch to quitting medications.
-
BSMAT: Helping people with HIV quit smoking through routine support
A HIV care program in Botswana aims to help people living with HIV quit smoking using a proven 5A brief intervention plus support medication.
-
Improving treatment for people with HIV who smoke and drink in Nairobi, Kenya
A study tests a new plan to help people with HIV in Nairobi quit smoking and reduce heavy drinking, using a low-cost medicine and counseling.
-
I-STOP: a mobile health program to help people with HIV quit smoking
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.